Functional imaging: PET

Handbook of Clinical Neurology

Volumn 111, Issue , 2013, Pages 767-776

  Kumar, Ajay ^a   Chugani, Harry T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876784380     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52891-9.00079-8     Document Type: Chapter

References (97)

1. Arnold S., Berthele A., Drzezga A., et al. Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia. Epilepsia 2000, 41:818-824.
2. Asano E., Chugani D.C., Muzik O., et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 2000, 54:1976-1984.
3. Banati R.B., Goerres G.W., Myers R., et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999, 53:2199-2203.
4. Bartenstein P.A., Duncan J.S., Prevett M.C., et al. Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatry 1993, 56:1295-1302.
5. Bartenstein P.A., Prevett M.C., Duncan J.S., et al. Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography. Epilepsy Res 1994, 18:119-125.
6. Biraben A., Semah F., Ribeiro M.J., et al. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology 2004, 63:73-77.
7. Bouilleret V., Dupont S., Spelle L., et al. Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol 2002, 51:202-208.
8. Bouilleret V., Semah F., Biraben A., et al. Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis. J Nucl Med 2005, 46:540-547.
9. Chugani H.T., Conti J.R. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol 1996, 11:44-48.
10. Chugani H.T., Mazziotta J.C., Engel J., et al. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Ann Neurol 1987, 21:4-13.
11. Chugani H.T., Mazziotta J.C., Phelps M.E. Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr 1989, 114:244-253.
12. Chugani H.T., Shields W.D., Shewmon D.A., et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990, 27:406-413.
13. Chugani H.T., Shewmon D.A., Khanna S., et al. Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol 1993, 9:10-15.
14. Chugani H.T., Shewmon D.A., Shields W.D., et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia 1993, 34:764-771.
15. Chugani H.T., Da Silva E., Chugani D.C. Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol 1996, 39:643-649.
16. Chugani D.C., Chugani H.T., Muzik O., et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 1998, 44:858-866.
17. Chugani H.T., Asano E., Sood S. Surgical treatment of West syndrome. Progress in Epileptic Spasms and West Syndrome 2007, 143-151. John Libbey, Montrouge, France. F. Guzzetta, B. Dalla Bernardina, R. Guerrini (Eds.).
18. Curatolo P., Seri S., Verdecchia M., et al. Infantile spasms in tuberous sclerosis complex. Brain Dev 2001, 23:502-507.
19. da Silva E.A., Chugani D.C., Muzik O., et al. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 1997, 38:1198-1208.
20. Depositario-Cabacar D.T., Riviello J.J., Takeoka M. Present status of surgical intervention for children with intractable seizures. Curr Neurol Neurosci Rep 2008, 8:123-129.
21. Didelot A., Ryvlin P., Lothe A., et al. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 2008, 131:2751-2764.
22. Fedi M., Berkovic S.F., Scheffer I.E., et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2008, 71:795-798.
23. Frost J.J., Mayberg H.S., Fisher R.S., et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 1988, 23:231-237.
24. Gaillard W.D., Bhatia S., Bookheimer S.Y., et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995, 45:123-126.
25. Gaily E.K., Shewmon D.A., Chugani H.T., et al. Asymmetric and asynchronous infantile spasms. Epilepsia 1995, 36:873-882.
26. Giovacchini G., Toczek M.T., Bonwetsch R., et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 2005, 46:1128-1135.
27. Goerres G.W., Revesz T., Duncan J., et al. Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. AJR Am J Roentgenol 2001, 176:1016-1018.
28. Hammers A., Koepp M.J., Hurlemann R., et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 2002, 125:2257-2271.
29. Hammers A., Asselin M.C., Hinz R., et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain 2007, 130:1009-1016.
30. Hasler G., Bonwetsch R., Giovacchini G., et al. 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 2007, 62:1258-1264.
31. Henry T.R., Sutherling W.W., Engel J., et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 1991, 10:174-182.
32. Henry T.R., Frey K.A., Sackellares J.C., et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993, 43:1998-2006.
33. Honbolygo F., Csepe V., Fekeshazy A., et al. Converging evidences on language impairment in Landau-Kleffner Syndrome revealed by behavioral and brain activity measures: a case study. Clin Neurophysiol 2006, 117:295-305.
34. Iinuma K., Yokoyama H., Otsuki T., et al. Histamine H1 receptors in complex partial seizures. Lancet 1993, 341:238.
35. Joo E.Y., Lee E.K., Tae W.S., et al. Unitemporal vs bitemporal hypometabolism in mesial temporal lobe epilepsy. Arch Neurol 2004, 61:1074-1078.
36. Juhasz C., Chugani D.C., Muzik O., et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 2000, 55:825-835.
37. Juhasz C., Behen M.E., Muzik O., et al. Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression. Epilepsia 2001, 42:991-1001.
38. Juhasz C., Chugani D.C., Muzik O., et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 2001, 56:1650-1658.
39. Juhasz C., Chugani D.C., Muzik O., et al. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 2003, 60:960-968.
40. Juhasz C., Batista C.E., Chugani D.C., et al. Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome. Eur J Paediatr Neurol 2007, 11:277-284.
41. Kagawa K., Chugani D.C., Asano E., et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 2005, 20:429-438.
42. Kim Y.K., Lee D.S., Lee S.K., et al. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 2002, 43:1167-1174.
43. Knowlton R.C., Laxer K.D., Ende G., et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol 1997, 42:829-837.
44. Knowlton R.C., Elgavish R.A., Bartolucci A., et al. Functional imaging: II Prediction of epilepsy surgery outcome. Ann Neurol 2008, 64:35-41.
45. Koepp M.J., Woermann F.G. Imaging structure and function in refractory focal epilepsy. Lancet Neurol 2005, 4:42-53.
46. Koepp M.J., Richardson M.P., Brooks D.J., et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: An objective in vivo analysis. Brain 1996, 119:1677-1687.
47. Koepp M.J., Labbe C., Richardson M.P., et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997, 120:1865-1876.
48. Koepp M.J., Richardson M.P., Brooks D.J., et al. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet 1998, 352:952-955.
49. Koepp M.J., Hammers A., Labbe C., et al. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000, 54:332-339.
50. Kramer U., Sue W.C., Mikati M.A. Focal features in West syndrome indicating candidacy for surgery. Pediatr Neurol 1997, 16:213-217.
51. Kumar A., Chugani H.T., Luat A., et al. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol 2008, 38:439-442.
52. Kumlien E., Bergstrom M., Lilja A., et al. Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy. Epilepsia 1995, 36:712-721.
53. Kumlien E., Hartvig P., Valind S., et al. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 1999, 40:30-37.
54. Kumlien E., Nilsson A., Hagberg G., et al. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurol Scand 2001, 103:360-366.
55. Lamusuo S., Pitkanen A., Jutila L., et al. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 2000, 54:2252-2260.
56. Lamusuo S., Jutila L., Ylinen A., et al. [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Arch Neurol 2001, 58:933-939.
57. Lee J.S., Asano E., Muzik O., et al. Sturge-Weber syndrome: correlation between clinical course and FDG PET findings. Neurology 2001, 57:189-195.
58. Lee J.S., Juhasz C., Kaddurah A.K., et al. Patterns of cerebral glucose metabolism in early and late stages of Rasmussen's syndrome. J Child Neurol 2001, 16:798-805.
59. Liew C.J., Lim Y.M., Bonwetsch R., et al. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy. Epilepsia 2009, 50:234-239.
60. Luat A.F., Chugani H.T., Asano E., et al. Episodic receptive aphasia in a child with Landau-Kleffner Syndrome: PET correlates. Brain Dev 2006, 28:592-596.
61. Madar I., Lesser R.P., Krauss G., et al. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol 1997, 41:358-367.
62. Maquet P., Hirsch E., Dive D., et al. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study. Epilepsia 1990, 31:778-783.
63. Maquet P., Hirsch E., Metz-Lutz M.N., et al. Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep. Brain 1995, 118:1497-1520.
64. Mayberg H.S., Sadzot B., Meltzer C.C., et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 1991, 30:3-11.
65. Merlet I., Ostrowsky K., Costes N., et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 2004, 127:900-913.
66. Merlet I., Ryvlin P., Costes N., et al. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage 2004, 22:886-896.
67. Meschaks A., Lindstrom P., Halldin C., et al. Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Arch Neurol 2005, 62:946-950.
68. Muzik O., da Silva E.A., Juhasz C., et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000, 54:171-179.
69. Natsume J., Kumakura Y., Bernasconi N., et al. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 2003, 60:756-761.
70. Noachtar S., Borggraefe I. Epilepsy surgery: a critical review. Epilepsy Behav 2009, 15:66-72.
71. Ollenberger G.P., Byrne A.J., Berlangieri S.U., et al. Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy. Eur J Nucl Med Mol Imaging 2005, 32:1311-1316.
72. Patil S., Biassoni L., Borgwardt L. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med 2007, 37:357-381.
73. Picard F., Bruel D., Servent D., et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 2006, 129:2047-2060.
74. Prevett M.C., Cunningham V.J., Brooks D.J., et al. Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography. Epilepsy Res 1994, 19:71-77.
75. Rastogi S., Lee C., Salamon N. Neuroimaging in pediatric epilepsy: a multimodality approach. Radiographics 2008, 28:1079-1095.
76. Raymond A.A., Fish D.R., Sisodiya S.M., et al. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: Clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995, 118:629-660.
77. Richardson M.P., Koepp M.J., Brooks D.J., et al. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998, 51:485-492.
78. Rintahaka P.J., Chugani H.T., Messa C., et al. Hemimegalencephaly: evaluation with positron emission tomography. Pediatr Neurol 1993, 9:21-28.
79. Rintahaka P.J., Chugani H.T., Sankar R. Landau-Kleffner syndrome with continuous spikes and waves during slow-wave sleep. J Child Neurol 1995, 10:127-133.
80. Ryvlin P., Bouvard S., Le Bars D., et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 1998, 121:2067-2081.
81. Savic I., Ingvar M., Stone-Elander S. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993, 56:615-621.
82. Savic I., Thorell J.O., Roland P. [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995, 36:1225-1232.
83. Savic I., Lindstrom P., Gulyas B., et al. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 62:1343-1351.
84. Shiraishi H., Takano K., Shiga T., et al. Possible involvement of the tip of temporal lobe in Landau-Kleffner syndrome. Brain Dev 2007, 29:529-533.
85. Swartz B.E., Halgren E., Delgado-Escueta A.V., et al. Neuroimaging in patients with seizures of probable frontal lobe origin. Epilepsia 1989, 30:547-558.
86. Swartz B.W., Khonsari A., Vrown C., et al. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and " frontal plus" epilepsy. Epilepsia 1995, 36:388-395.
87. Szelies B., Weber-Luxenburger G., Pawlik G., et al. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 1996, 3:109-118.
88. Szelies B., Sobesky J., Pawlik G., et al. Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET. Eur J Neurol 2002, 9:137-142.
89. Theodore W.H., Carson R.E., Andreasen P., et al. PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy. Epilepsy Res 1992, 13:129-139.
90. Theodore W.H., Sato S., Kufta C.V., et al. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia 1997, 38:81-86.
91. Toczek M.T., Carson R.E., Lang L., et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003, 60:749-756.
92. Uijl S.G., Leijten F.S., Arends J.B., et al. The added value of [18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia 2007, 48:2121-2129.
93. Wakamoto H., Chugani D.C., Juhasz C., et al. Alpha-methyl-l-tryptophan positron emission tomography in epilepsy with cortical developmental malformations. Pediatr Neurol 2008, 39:181-188.
94. Werhahn K.J., Landvogt C., Klimpe S., et al. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia 2006, 47:1392-1396.
95. Willmann O., Wennberg R., May T., et al. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy: A meta-analysis. Seizure 2007, 16:509-520.
96. Wyllie E., Comair Y.G., Kotagal P., et al. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998, 44:740-748.
97. You S.J., Lee J.K., Ko T.S. Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia. Brain Dev 2007, 29:167-170.